Overview Request Sample Pages Request Customization Download PDF
You are viewing: New Zealand Veterinary Vaccines Market analysis
Part of: Veterinary Vaccines Market (Global)

The New Zealand Veterinary Vaccines Market was valued at $34.43 Million in 2024 and projected to reach to $44.97 Million by 2029, representing a compound annual growth rate of CAGR 5.5%. New Zealand's veterinary vaccines market is positioned for steady growth through 2029, supported by the country's strong agricultural foundation and increasing emphasis on animal health management.

New Zealand Veterinary Vaccines Market Trends and Insights

  • The market in New Zealand is driven by increasing livestock production, rising pet ownership, and heightened awareness of animal health and disease prevention.
  • New Zealand's strong agricultural sector and export-oriented farming practices create sustained demand for effective vaccination programs across both companion and production animals. The veterinary vaccines landscape in New Zealand reflects the country's commitment to biosecurity and animal welfare standards.
  • New Zealand's regulatory environment and emphasis on disease control in both domestic and export markets support consistent market expansion.
  • Between 2024 and 2029, New Zealand is expected to see growing adoption of advanced vaccine formulations and preventive healthcare protocols, particularly in dairy and sheep farming sectors that form the backbone of the nation's agricultural economy..

Key Market Statistics

  • CAGR (2024-2029) : CAGR 5.5%
  • Market Size, 2024 : ~USD 34.43
  • Forecast, 2029 : ~USD 44.97
  • Country : New Zealand

New Zealand Veterinary Vaccines Market Overview

Market Valuation :

New Zealand's veterinary vaccines market is valued at USD 34.43 million in 2024, with a projected CAGR of 5.5% through 2029, reaching USD 44.97 million by forecast end.

Agricultural Sector Strength :

New Zealand's export-oriented farming practices and robust agricultural sector drive consistent demand for livestock vaccination programs, supporting market expansion across dairy, beef, and sheep farming.

Pet Ownership Growth :

Rising pet ownership rates in New Zealand are increasing demand for companion animal vaccines, creating new revenue streams beyond traditional livestock vaccination markets.

Disease Prevention Focus :

Heightened awareness of animal health and disease prevention among New Zealand farmers and pet owners is accelerating adoption of preventive vaccination strategies and biosecurity measures.

New Zealand Veterinary Vaccines Market Dynamics

  • The market benefits from New Zealand's export-focused farming sector, where vaccination compliance is critical for maintaining international trade standards and market access.
  • Rising pet ownership in urban areas complements traditional livestock demand, diversifying revenue opportunities for vaccine manufacturers and distributors.
  • Regulatory support for animal health standards and growing farmer awareness of disease prevention economics will continue driving market expansion at a 5.5% CAGR..

Related Ecosystem

Animal Health

Top Technologies
  • Polymerase Chain Reaction (PCR) Tests
  • Porcine
  • Immunodiagnostics
  • Lateral Flow Assays
  • Microarrays
Top Companies
  • Zoetis Inc.
  • Patterson Companies, Inc.
  • Virbac
  • Elanco Animal Health Incorporated
  • BOEHRINGER INGELHEIM GMBH

    Pharmaceuticals

    Top Technologies
    • Bioreactors
    • Analytical Testing
    • Bioanalytical Testing Services
    • Cell Counters
    • Data Management Services
    Top Companies
    • Merck KGaA
    • Thermo Fisher Scientific Inc.
    • SANOFI
    • NOVARTIS
    • Pfizer Inc.

      Key Takeaways

      • New Zealand's veterinary vaccines market is valued at USD 34.43 million in 2024 and will grow to USD 44.97 million by 2029, representing a 5.5% CAGR.
      • New Zealand's strong agricultural sector and biosecurity focus drive consistent demand for livestock vaccination programs across dairy and sheep farming.
      • Rising pet ownership and increased animal health awareness in New Zealand support growth in companion animal vaccine adoption.
      • New Zealand's export-oriented farming practices and regulatory standards create sustained market opportunities for advanced vaccine formulations through 2029.

      New Zealand Veterinary Vaccines Market Report Scope

      Report Metric Details
      Base Year 2024
      Fastest Growing Segment CHINA (Disease)
      Forecast Period 2024–2029
      Growth Rate CAGR of 6.1% from 2024 to 2029
      Largest Segment VETERINARY HOSPITALS (End User)
      Market Size Base Year 9.91 (2024)
      Revenue Forecast 13.33 (2029)
      Segments Covered Type, Disease, Technology, Route Of Administration, End User

      New Zealand Veterinary Vaccines Market Report Segmentation

      5 segment dimensions are covered across the global market.

      By Type

      • Aquaculture Vaccines
      • Bovine Diseases
      • Bovine Vaccines
      • Canine Diseases
      • Canine Vaccines
      • Companion Animal Vaccines
      • Feline Diseases
      • Feline Vaccines
      • Livestock Vaccines
      • Other Veterinary Vaccines
      • Porcine Vaccines
      • Poultry Vaccines
      • Small Ruminant Diseases
      • Small Ruminant Vaccines

      By Disease

      • Aquaculture Diseases
      • Companion Animal Diseases
      • Livestock Diseases
      • Other Veterinary Diseases
      • Porcine Diseases
      • Poultry Diseases

      By Technology

      • Inactivated Vaccines
      • Live Attenuated Vaccines
      • Other Vaccine Technologies
      • Recombinant Vaccines
      • Toxoid Vaccines

      By Route Of Administration

      • Intramuscular
      • Intramuscular Route Of Administration
      • Intranasal/Spray
      • Intranasal/Spray Route Of Administration
      • Intraocular
      • Intraocular Route Of Administration
      • Oral
      • Oral Route Of Administration
      • Other Routes Of Administration
      • Subcutaneous
      • Subcutaneous Route Of Administration

      By End User

      • Other End Users
      • Veterinary Clinics
      • Veterinary Hospitals

      Target Audience

      • Veterinary Vaccine Manufacturers : Manufacturers need New Zealand market data to identify regional demand patterns, optimize product portfolios for livestock and companion animals, and develop localized go-to-market strategies.
      • Pharmaceutical Distributors & Wholesalers : Distributors require market sizing and growth forecasts to plan inventory, negotiate supplier contracts, and allocate resources effectively across New Zealand's veterinary vaccine supply chain.
      • Agricultural & Livestock Producers : Farmers and farming organizations need market insights to understand vaccination trends, cost-benefit analyses, and disease prevention strategies relevant to New Zealand's export-focused agricultural sector.
      • Veterinary Clinics & Animal Health Services : Veterinary practitioners need market data to anticipate vaccine availability, pricing trends, and demand patterns to optimize their service offerings and inventory management in New Zealand.
      • Investment & Business Development Teams : Investors and business development professionals need country-specific market analysis to evaluate acquisition targets, partnership opportunities, and expansion potential in New Zealand's veterinary sector.

      Key Companies in the New Zealand Veterinary Vaccines Market

      CompanyHQOwnershipStrongest segments
      KBNP,INC.South KoreaPrivate CompanyPoultry and swine medicines,Cattle and aquaculture products,Companion animal medicines,
      KOMIPHARM INTERNATIONALSouth KoreaPublic CompanyVeterinary vaccines,Veterinary pharmaceuticals (injectable, oral, topical),Disinfectants and bio-fertilizers,
      BAYER AGGermanyPublic CompanyCrop Science,Pharmaceuticals,Consumer Health,
      HESKA CORPORATIONUnited StatesPrivate CompanyIn-clinic analyzers (chemistry, hematology, blood gas, coagulation, immunodiagnostics),Imaging and informatics (digital radiography, mobile DR, ultrasound, Cloudbank, telecytology),Point-of-care infectious disease tests and allergy products/services,
      QUIMTIA S.A.BrazilPrivate CompanyPoultry feed and premix,Swine feed and premix,Bovine and ruminant nutrition,
      TEREOSFrancePrivate CompanySugar and sweetening ingredients (including organic cane and beet sugar),Starches and derivatives (food, industrial, bioplastics, corrugated cardboard),Alcohol and ethanol (food, industrial, fuel, and pharma uses),
      SANOFIFrancePublic CompanyPediatric and combination vaccines (polio, pertussis, Hib, hexavalent),Other vaccines (RSV, hepatitis A, typhoid, yellow fever, rabies),Immunology and inflammation therapies,
      PATTERSON COMPANIES, INCUnited StatesPrivate CompanyDental consumables and equipment,Dental software and practice optimization,Animal health products and private label,
      MERCK & CO., INC.United StatesPublic CompanyOncology (Keytruda, Keytruda Qlex, Welireg, ADC collaborations),Vaccines (Gardasil, pediatric, pneumococcal, rotavirus),Cardiometabolic, infectious disease, and other human pharma,
      ZOETISUnited StatesPublic CompanyParasiticides,Vaccines,Dermatology,
      ELANCOUnited StatesPublic CompanyCompanion animal parasiticides (Seresto, K-9 Advantage, Advantix, Advocate, Credelio, Interceptor Plus, Drontal),Companion animal vaccines and therapeutics (Galliprant, Atopica, Onsior, Tru Family, cardiovascular and dermatology),Farm animal feed additives and antibiotics (Rumensin, Experior, Baytril, Denagard, Pulmotil, Surmax, Hemicell),
      CEVAUnited StatesPublic Company5G/5G-Advanced baseband DSP and RAN IP (PentaG-RAN, Ceva XC20/XC21/XC23, PentaG2, Ceva-BX2),Connectivity IP (Ceva-Waves Bluetooth, Wi-Fi, UWB, Links, DragonFly NB-IoT),Sensing, audio, and sensor-fusion IP (Ceva-SensPro, Ceva-BX1, ClearVox, RealSpace, MotionEngine),
      VIRBACFrancePublic CompanyCompanion animal parasiticides (e.g., Prevexto),Companion animal specialty therapeutics (dermatology, stress, mobility, kidney, dental),Companion animal vaccines and antibiotics,
      PHIBRO ANIMAL HEALTH CORPORATIONUnited StatesPublic CompanyAnimal Health (antibacterials, anticoccidials, nutritional specialties, vaccines, adjuvants, microbial and bioproducts),Mineral Nutrition (trace mineral formulations and concentrations),Performance Products (specialty ingredients for personal care, industrial chemicals, catalysts),
      HESTER BIOSCIENCES LIMITEDIndiaPublic CompanyPoultry vaccines,Large-animal vaccines (cattle, small ruminants),Companion animal and specialty biologics,
      NEOGEN CORPORATIONUnited StatesPublic CompanyFood Safety diagnostics, media, and sanitation,Animal Safety reagents, instruments, and animal care products,Genomics services for livestock and companion animals,
      TIANJIN RINGPU BIO-TECHNOLOGY CO., LTD.ChinaPublic CompanyVeterinary vaccines,Chemical drugs and APIs,Feed and functional additives,
      CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.ChinaPublic CompanyAnimal Disease Epidemic Prevention (vaccines and biologicals),Animal Disease Treatment (veterinary chemical products),Animal Nutrition (feed, premixes, additives, raw material trade),
      JINYU BIO-TECHNOLOGY CO., LTD.ChinaPublic CompanyPorcine vaccines (PRRS, pseudorabies, FMD, circovirus, swine fever, influenza, TGE),Poultry vaccines (avian influenza, Newcastle disease, IBD, IB, egg drop syndrome),Ruminant and brucellosis vaccines,

      KBNP,INC.

      KBNP,INC. is a private company based in South Korea with 96 employees, founded in 1988.

      KOMIPHARM INTERNATIONAL

      KOMIPHARM INTERNATIONAL is a public company based in South Korea with 161 employees, established in 1972.

      BAYER AG

      Bayer AG is a public company based in Germany with 87,757 employees, founded in 1863.

      HESKA CORPORATION

      HESKA CORPORATION is a private company based in the United States with 808 employees, founded in 1988.

      QUIMTIA S.A.

      QUIMTIA S.A. is a private company based in Brazil, established in 1975.

      TEREOS

      TEREOS is a private company based in France with 10,241 employees, founded in 1996.

      SANOFI

      Sanofi is a public company based in France with 74,846 employees, established in 1994.

      PATTERSON COMPANIES, INC

      PATTERSON COMPANIES, INC is a private company based in the United States with 7,600 employees, founded in 1877.

      MERCK & CO., INC.

      Merck & Co., Inc. is a public company based in the United States with 74,000 employees, established in 1891.

      ZOETIS

      Zoetis is a public company based in the United States with 14,500 employees, founded in 2012.

      ELANCO

      Elanco is a public company based in the United States with 9,650 employees, founded in 1954.

      CEVA

      Ceva is a public company based in the United States with 400 employees, established in 1999.

      VIRBAC

      Virbac is a public company based in France with 6,442 employees, founded in 1968.

      PHIBRO ANIMAL HEALTH CORPORATION

      Phibro Animal Health Corporation is a public company based in the United States with 2,475 employees, established in 1946.

      HESTER BIOSCIENCES LIMITED

      HESTER BIOSCIENCES LIMITED is a public company based in India, founded in 1987.

      NEOGEN CORPORATION

      Neogen Corporation is a public company based in the United States with 2,974 employees, established in 1981.

      TIANJIN RINGPU BIO-TECHNOLOGY CO., LTD.

      TIANJIN RINGPU BIO-TECHNOLOGY CO., LTD. is a public company based in China with 2,803 employees, founded in 1998.

      CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.

      CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD. is a public company based in China with 3,996 employees, established in 1998.

      JINYU BIO-TECHNOLOGY CO., LTD.

      JINYU BIO-TECHNOLOGY CO., LTD. is a public company based in China with 1,881 employees, founded in 1992.

      Reasons to Buy this Report

      • Country-Specific Market Sizing : Access precise market valuation data for New Zealand (USD 34.43M in 2024) with accurate 5-year forecasts, enabling targeted investment and expansion decisions in this specific market.
      • Agricultural Sector Insights : Understand New Zealand's export-oriented farming dynamics and livestock vaccination requirements, critical for suppliers seeking to align products with local agricultural practices and trade compliance.
      • Pet Market Opportunity Analysis : Identify growth opportunities in New Zealand's rising pet ownership segment, distinct from livestock markets, with tailored strategies for companion animal vaccine distribution and marketing.
      • Competitive Landscape Intelligence : Gain insights into New Zealand-specific competitive dynamics, regulatory environment, and market barriers to entry, enabling informed go-to-market strategies for this regional market.
      • Growth Trajectory Planning : Leverage the 5.5% CAGR forecast to develop realistic revenue projections and resource allocation plans specific to New Zealand's veterinary vaccine market through 2029.

      Frequently asked questions

      What is the current size of New Zealand's veterinary vaccines market?

      New Zealand's veterinary vaccines market was valued at USD 34.43 million in 2024 and is projected to reach USD 44.97 million by 2029.

      What is the expected growth rate for veterinary vaccines in New Zealand?

      New Zealand's veterinary vaccines market is expected to grow at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2029.

      What drives demand for veterinary vaccines in New Zealand?

      Demand in New Zealand is driven by the country's strong agricultural sector, rising pet ownership, biosecurity requirements, and export-oriented farming practices that prioritize animal health and disease prevention.

      Which animal segments are most important in New Zealand's veterinary vaccines market?

      New Zealand's market is dominated by livestock vaccines, particularly for dairy cattle and sheep, alongside growing companion animal vaccine segments driven by increased pet ownership.

      How does New Zealand's regulatory environment impact the veterinary vaccines market?

      New Zealand's strict biosecurity standards and regulatory framework support market growth by ensuring consistent demand for approved vaccines and creating barriers to entry that protect established market players.

      RESEARCH METHODOLOGY

      This study involved the extensive use of both primary and secondary sources. The research process involved examining various factors affecting the industry to identify segmentation types, industry trends, key players, the competitive landscape, fundamental market dynamics, and key players' strategies.

      Secondary Research

      The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, SEC filings of companies and publications from government sources such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), American Veterinary Medical Association (AVMA), Animal Health Institute (AHI), National Animal Health Laboratory Network (NAHLN), and Food and Agriculture Organization of the United Nations (FAO) were referred to identify and collect information for the global veterinary vaccines market study. It was also used to obtain important information about key players, market classification & segmentation according to industry trends, down to the bottom-most level, and key developments from market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

      Primary Research

      In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and other key executives from various companies and organizations in the veterinary vaccines market. The primary sources from the demand side include hospitals & clinics, physiotherapy clinics, and home care settings. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

      A breakdown of the primary respondents is provided below:

      Veterinary Vaccines Market

      *C-level primaries include CEOs, CFOs, COOs, and VPs.

      *Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

      Note: Companies are classified into tiers based on their total revenue. As of 2025, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.

      Source: MarketsandMarkets Analysis

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      For the global market value, annual revenues were calculated using revenue mappings of major product manufacturers and OEMs active in the global veterinary vaccines market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players (who contribute at least 70-75% of the market share at the global level). Also, the global veterinary vaccines   market was split into various segments and sub-segments based on:

      • List of major players operating in the veterinary vaccines   products market at the regional and/or country level
      • Product mapping of various veterinary vaccine manufacturers at the regional and/or country level
      • Mapping of annual revenue generated by listed major players from veterinary vaccines (or the nearest reported business unit/product category)
      • Revenue mapping of major players to cover at least 70-75% of the global market share as of 2025
      • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
      • Summation of the market value of all segments/subsegments to arrive at the global point-of-care  diagnostics market

      The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

      Market Size Estimation (Bottom Up approach & Top down approach)

      Veterinary Vaccines Market

      Data Triangulation

      After determining the overall size of the global veterinary vaccines market using the above-mentioned methodology, the market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, where applicable, to complete the overall market engineering process and derive the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.

      Market Definition

      A veterinary vaccine is a biological preparation that provides immunity by stimulating an animal’s immune system to recognize and combat a specific pathogen. The veterinary vaccines market includes live attenuated, inactivated, recombinant, and toxoid vaccines for a wide range of animals, including poultry, livestock, porcine, aquaculture, and companion animals. Vaccination improves animal health, reduces the incidence of zoonotic diseases, supports higher productivity, and helps secure economic stability.   

      Stakeholders

      • Animal vaccine manufacturers
      • Animal healthcare product manufacturers
      • Animal vaccine distributors and wholesalers
      • Animal welfare associations
      • Veterinary clinics and care centers
      • Research and consulting firms
      • Veterinary Research and Development Organizations 
      • Contract research organizations
      • Contract manufacturing organizations
      • Venture capitalists

      Report Objectives

      • To define, measure, and describe the global veterinary vaccines  market by type, disease, technology, route of administration, and end user
      • To provide detailed information about the major factors influencing the market growth (drivers, restraints, challenges, and opportunities)
      • To strategically analyze the regulatory scenario, pricing, value chain analysis, supply chain analysis, ecosystem analysis, technology analysis, Porter’s Five Forces analysis, pipeline analysis, and patent analysis
      • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
      • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
      • To forecast the size of market segments in North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
      • To strategically analyze the market structure, profile the key players in the global veterinary vaccines  market, and comprehensively analyze their core competencies
      • To track and analyze company developments such as acquisitions, partnerships, expansions, and product launches and approvals in the veterinary vaccines  market

      Available Customizations

      With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

      GEOGRAPHIC ANALYSIS

      • Further breakdown of the Rest of Europe veterinary vaccines market into Russia, Switzerland, Denmark, Austria, and others
      • Further breakdown of the Rest of Asia Pacific veterinary vaccines  market into Taiwan and others
      • Further breakdown of the Rest of Latin America veterinary vaccines  market into Argentina, Colombia, Chile, Ecuador, and others
      • Further breakdown of the Southeast Asia veterinary vaccines market into Malaysia, Singapore, Australia, and others  

      COMPETITIVE LANDSCAPE ASSESSMENT

      • Market share analysis, by region (North America and Europe), which provides market shares of the top 3-5 key players in the veterinary vaccines  market
      • Competitive leadership mapping for established players in the US  

       

      Get the Full Veterinary Vaccines Market Report

      Full forecast, segment splits, and company analysis for all Veterinary Vaccines Market.

      Download Sample Pages Buy Report

      METHODOLOGY

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      Cite this Research
      DMCA.com Protection Status